Home » Newsletters » BioWorld Science

BioWorld Science

Jan. 16, 2013

View Archived Issues

Novel transgenic pig model of familial hypercholesterolemia

Vertex Pharmaceuticals synthesizes new protein kinase inhibitors

Argos Therapeutics enrolls first patients in phase III ADAPT study

Researchers at Amgen present novel TRPM8 antagonists

The Wisconsin Alumni Research Foundation patents novel vitamin D analogues

Celecoxib shows promise as adjunctive treatment in children with autism

AstraZeneca and Vanderbilt University enter collaboration

Galapagos delivers second candidate drug to Janssen Pharmaceutica

French grant awarded for development of epicutaneous pediatric RSV vaccine

Four NIH-supported studies focus on new treatments for Alzheimer's disease

CorMedix signs marketing agreement with MKM Co-Pharma for Neutrolin

Cytos updates on phase IIb allergic asthma study

Tysabri label update sought from the FDA and EMA

Detection of endometrial and ovarian cancers through DNA screening of Pap smears

European approval for Amyvid diagnostic radiopharmaceutical

FDA accepts for filing Tarceva sNDA

Unigene Laboratories designs polypeptides with anti-inflammatory activity

Isis Pharmaceuticals patents antisense modulators of FGFR-4

European approval for new 800-mg tablet of Prezista

Novel GnRH receptor antagonists emerge from Bayer R&D

New antidiabetic agents described in Metabolic Solutions Development patent

Zenobia Therapeutics develops novel LRRK2 inhibitors

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 20, 2026.
Biohaven reports details on discovery of BHV-2100
BioWorld Science
Transient receptor potential melastatin 3 (TRPM3) is a calcium-permeable TRP channel that is highly expressed in somatosensory neurons, including nociceptors of...
Meta-analysis: Anti-amyloid Alzheimer’s drugs not ‘clinically meaningful’
BioWorld
The ongoing controversy over the effectiveness of anti-amyloid drugs is about to get more heated, after a review of clinical trials showed statistically...
New GABA(B) receptor PAMs revealed in Addex Pharma patents
BioWorld Science
Addex Pharma SA has disclosed new GABA(B) receptor positive allosteric modulators (PAMs) potentially useful for the treatment of chronic cough, urinary...
Novel caspase-2 inhibitor shows in vivo neuroprotective effects
BioWorld Science
Caspase-2-mediated cleavage of tau at Asp314 generates a neurotoxic fragment, Δtau314, that drives early synaptic dysfunction in Alzheimer’s disease (AD) and...